8-K: TerrAscend Reports Mixed Q3 2024 Results: Revenue Declines but Positive Cash Flow Continues

TerrAscend's Q3 2024 results show a slight revenue decrease but maintain positive cash flow and strategic expansion.

Summary

• TerrAscend reported a net revenue of $74.2 million for the third quarter of 2024, a decrease from $77.5 million in the previous quarter.
• The company's gross profit margin was 48.8%, a slight increase from 48.6% in Q2 2024.
• GAAP net loss from continuing operations was $21.4 million, compared to a net loss of $6.2 million in the second quarter.
• EBITDA from continuing operations was $6.6 million, down from $18.6 million in the previous quarter.
• Adjusted EBITDA from continuing operations was $13.7 million, compared to $15.6 million in Q2 2024.
• The company achieved its ninth consecutive quarter of positive cash flow from continuing operations and fifth consecutive quarter of positive free cash flow.
• TerrAscend closed a $140 million senior secured term loan with a 12.75% interest rate, maturing in August 2028.
• They also announced a definitive agreement to enter the Ohio market through the acquisition of a dispensary.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While the company maintains positive cash flow and is expanding, the significant increase in net loss and decrease in EBITDA are concerning. The high interest rate on the term loan is also a negative factor.

Positives

• TerrAscend achieved its ninth consecutive quarter of positive cash flow from continuing operations.
• The company also achieved its fifth consecutive quarter of positive free cash flow.
• Gross profit margin saw a slight increase to 48.8%.
• Maryland's wholesale revenue grew by 26% quarter-over-quarter.
• The company secured a $140 million senior secured term loan without warrants or prepayment penalties.
• TerrAscend is expanding into the Ohio market through acquisition.
• The company has implemented a new enterprise resource planning (ERP) tech stack.

Negatives

• Net revenue decreased to $74.2 million from $77.5 million in the previous quarter.
• GAAP net loss from continuing operations increased to $21.4 million from $6.2 million in Q2 2024.
• EBITDA from continuing operations decreased to $6.6 million from $18.6 million in the previous quarter.
• Adjusted EBITDA from continuing operations decreased to $13.7 million from $15.6 million in Q2 2024.
• General and administrative expenses increased to $31.6 million from $24.1 million in the previous quarter.

Risks

• The company faces risks related to federal, state, and local government laws and regulations, particularly concerning cannabis operations in the United States.
• Cannabis remains illegal under U.S. federal law, which poses a significant risk to the business.
• The company's financial performance could be adversely affected by changes in market conditions and regulatory environments.
• There are risks associated with the company's expansion strategy, including potential challenges in integrating acquired businesses.

Future Outlook

The company intends to continue its growth strategy, including pursuing M&A opportunities and expanding into new markets like Ohio. They are also monitoring regulatory developments, including the potential rescheduling of cannabis.

Management Comments

• Jason Wild, Executive Chairman, stated that the company's consistent positive cash flow supports its ability to execute its growth strategy, including aggressive pursuit of M&A.
• Jason Wild also mentioned the signing of a definitive agreement to enter Ohio through the acquisition of a well-situated and profitable dispensary.
• Management is looking forward to the upcoming DEA hearing concerning the proposed rescheduling of cannabis.

Industry Context

The cannabis industry is facing regulatory uncertainty and varying state-level legal frameworks. TerrAscend's expansion into Ohio reflects a broader trend of companies seeking growth opportunities in emerging markets. The company's focus on maintaining positive cash flow is crucial in a capital-intensive industry.

Comparison to Industry Standards

• TerrAscend's gross profit margin of 48.8% is competitive with other multi-state operators (MSOs) in the cannabis industry, such as Curaleaf and Green Thumb Industries, which have reported similar margins in recent quarters.
• The company's positive cash flow from operations is a positive sign, as many cannabis companies struggle with profitability and cash burn. Companies like Trulieve have also focused on achieving positive cash flow.
• The $140 million term loan at 12.75% interest is a relatively high cost of capital, reflecting the risk associated with the cannabis industry. Other MSOs have secured debt financing at varying rates, depending on their credit profile and market conditions.
• TerrAscend's expansion into Ohio is similar to other MSOs that are targeting new markets with growth potential. For example, companies like Cresco Labs have also expanded into new states through acquisitions.

Stakeholder Impact

• Shareholders may be concerned about the increased net loss and decreased profitability.
• Employees may be impacted by the company's expansion and restructuring efforts.
• Customers will benefit from the company's expansion into new markets and product offerings.
• Suppliers may see increased business opportunities as the company grows.
• Creditors are exposed to the company's debt obligations, including the new term loan.

Next Steps

• TerrAscend will continue to execute its growth strategy, including pursuing M&A opportunities.
• The company will focus on integrating the acquired dispensary in Ohio.
• Management will monitor the upcoming DEA hearing concerning the proposed rescheduling of cannabis.
• The company will continue its stock repurchase program.

Key Dates

Keywords

cannabis, financial results, revenue, EBITDA, cash flow, acquisition, Ohio, Maryland, New Jersey, dispensary, term loan, stock repurchase